| Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae: Importance of Combination … M Tumbarello, P Viale, C Viscoli, EM Trecarichi, F Tumietto, A Marchese, ... Clinical infectious diseases 55 (7), 943-950, 2012 | 1152 | 2012 |
| Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study M Tumbarello, EM Trecarichi, FG De Rosa, M Giannella, DR Giacobbe, ... Journal of Antimicrobial Chemotherapy 70 (7), 2133-2143, 2015 | 585 | 2015 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 493 | 2017 |
| Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by Klebsiella pneumoniae Carbapenemase–producing K. pneumoniae M Tumbarello, EM Trecarichi, A Corona, FG De Rosa, M Bassetti, ... Clinical Infectious Diseases 68 (3), 355-364, 2019 | 362 | 2019 |
| Risk factors for carbapenem‐resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study M Giannella, EM Trecarichi, FG De Rosa, V Del Bono, M Bassetti, ... Clinical Microbiology and Infection 20 (12), 1357-1362, 2014 | 270 | 2014 |
| Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital M Tumbarello, B Fiori, EM Trecarichi, P Posteraro, AR Losito, A De Luca, ... PloS one 7 (3), e33705, 2012 | 233 | 2012 |
| Identifying patients harboring extended-spectrum-β-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system M Tumbarello, EM Trecarichi, M Bassetti, FG De Rosa, T Spanu, ... Antimicrobial agents and chemotherapy 55 (7), 3485-3490, 2011 | 213 | 2011 |
| Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case–control–control study DR Giacobbe, V Del Bono, EM Trecarichi, FG De Rosa, M Giannella, ... Clinical Microbiology and Infection 21 (12), 1106. e1-1106. e8, 2015 | 210 | 2015 |
| Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience M Bassetti, N Castaldo, A Cattelan, C Mussini, E Righi, C Tascini, ... International journal of antimicrobial agents 53 (4), 408-415, 2019 | 151 | 2019 |
| Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae Infections: A Retrospective Observational Multicenter Study M Tumbarello, F Raffaelli, M Giannella, E Mantengoli, A Mularoni, ... Clinical Infectious Diseases 73 (9), 1664-1676, 2021 | 149 | 2021 |
| Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae M Tumbarello, EM Trecarichi, F Tumietto, V Del Bono, FG De Rosa, ... Antimicrobial agents and chemotherapy 58 (6), 3514-3520, 2014 | 113 | 2014 |
| A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... Mayo Clinic Proceedings 91 (10), 1362-1371, 2016 | 107 | 2016 |
| ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva). Infections caused by KPC-producing Klebsiella pneumoniae: differences in … M Tumbarello, EM Trecarichi, FG De Rosa, M Giannella, DR Giacobbe, ... J Antimicrob Chemother 70 (7), 2133-43, 2015 | 98 | 2015 |
| Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units DR Giacobbe, M Mikulska, M Tumbarello, E Furfaro, M Spadaro, ... Critical Care 21, 1-9, 2017 | 84 | 2017 |
| Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study A Russo, M Bassetti, G Ceccarelli, N Carannante, AR Losito, M Bartoletti, ... Journal of Infection 79 (2), 130-138, 2019 | 81 | 2019 |
| Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes M Tumbarello, EM Trecarichi, B Fiori, AR Losito, T D'Inzeo, L Campana, ... Antimicrobial agents and chemotherapy 56 (6), 3224-3231, 2012 | 81 | 2012 |
| Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection M Giannella, EM Trecarichi, DR Giacobbe, FG De Rosa, M Bassetti, ... International Journal of Antimicrobial Agents 51 (2), 244-248, 2018 | 65 | 2018 |
| Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) M Bassetti, A Vena, DR Giacobbe, M Falcone, G Tiseo, M Giannella, ... Open forum infectious diseases 7 (5), ofaa139, 2020 | 58 | 2020 |
| Optimizing therapy in carbapenem-resistant Enterobacteriaceae infections M Tumbarello, AR Losito, H Giamarellou Current opinion in infectious diseases 31 (6), 566-577, 2018 | 58 | 2018 |
| Mortality in patients with early-or late-onset candidaemia FG De Rosa, EM Trecarichi, C Montrucchio, AR Losito, S Raviolo, ... Journal of Antimicrobial Chemotherapy 68 (4), 927-935, 2013 | 58 | 2013 |
